# Abbott Laboratories (ABT) — Q2-2023 Earnings Results

**Report date:** 2023-07-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2023

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 4.24%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.08 | N/A | +3.55% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No forward guidance data is available.

### What It Means

Abbott Laboratories reported a better-than-expected EPS for Q2 2023, which contributed to a positive stock reaction, with shares rising by 4.24%. However, there was no revenue figure provided, leaving some uncertainty about overall performance. The lack of guidance and management commentary means investors will need to wait for further information to assess future prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2023_